Cipla 2011 Harvard Case Solution & Analysis

Cipla 2011 Case Solution

Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while placing his company for growth in a changing regulatory landscape.

PUBLICATION DATE: April 12, 2011 PRODUCT #: 511050-PDF-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Related Case Solutions & Analyses:

Medical Equipment Inc. in Saudi Arabia The Ethics of Fundraising (C): The Catchere Gift and the Admissions Director Rein Chemical Co.: Specialty Division Governance Failure at Satyam Blind Spots: The Roots of Unethical Behaviour in Life and Work Ethics Hold the Key to Network Contradictions Going Flat: Pursuit of a Democratic Organizational Structure Alphatech India Limited: B2B Customer Retention Negotiation Analysis: An Introduction Martin Marietta: Managing Corporate Ethics (B)

Cipla 2011